PTPRC and non-small cell lung carcinoma: Together, these findings indicated that although the proportion of total ILCs among CD45+ cells showed no difference, ILC2s were enriched in both PBMCs and tumor tissues obtained from NSCLC patients and ILC1s decreased in NSCLC patients.